obesity tirzepatide New Breakthrough Drug Tirzepatide for Medical Weight Loss
Description
Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the companys tirzepatide (Mounjaro) compared with Novo Nordisks semaglutide (Wegovy) 2.4mg in 700 adult participants who have obesity or overweight with weight related comorbidities without Type 2 diabetes
PlexusDx helps you find the right form and dose for your unique metabolism and genetics
An expert shares the steps you can take to protect your muscles.
Medically supervised GLP-1 programme
